trial · primary record
MM-specific universal CAR T cells
Multiple Myeloma in Remission
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Percentage of patients with treatment related adverse effect |
| Registry ID | NCT06006741 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:39.755Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06006741
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.